Diagnostic Criteria for Heart Failure with Reduced Ejection Fraction
HFrEF is diagnosed when a patient has clinical signs and symptoms of heart failure AND a left ventricular ejection fraction (LVEF) ≤40%. 1
Core Diagnostic Components
The diagnosis requires two essential elements working together:
1. Clinical Manifestations of Heart Failure
Look specifically for:
- Dyspnea (at rest or with exertion)
- Peripheral edema (lower extremity swelling)
- Orthopnea or paroxysmal nocturnal dyspnea
- Exertional limitation or fatigue
- Pulmonary rales on examination
- Jugular venous distension
- S3 gallop on cardiac auscultation
2. Objective Cardiac Dysfunction
LVEF ≤40% measured by echocardiography is the defining threshold 1. This represents the most current guideline definition from the 2022 AHA/ACC/HFSA guidelines, which provides clear demarcation:
- HFrEF: LVEF ≤40%
- HFmrEF: LVEF 41-49%
- HFpEF: LVEF ≥50%
Supporting Diagnostic Evidence
Natriuretic Peptides (Critical Supportive Test)
Elevated natriuretic peptides strongly support the diagnosis and should be obtained in all patients with suspected HFrEF 1, 3, 4. These biomarkers:
- Provide objective evidence of cardiac stress
- Help differentiate cardiac from non-cardiac dyspnea
- Are typically higher in HFrEF compared to HFpEF (median ~4580 ng/L vs ~2900 ng/L for NT-proBNP) 5
Important caveat: Normal natriuretic peptide levels do not exclude HFrEF diagnosis if clinical symptoms and reduced LVEF are present 1.
Cardiac Imaging
Echocardiography is the primary imaging modality for:
- Quantifying LVEF (the diagnostic threshold)
- Assessing left ventricular dilatation
- Identifying adverse cardiac remodeling
- Evaluating valvular abnormalities
Additional imaging (cardiac MRI, coronary CT angiography) may be indicated for specific clinical scenarios 6.
Diagnostic Algorithm
- Identify clinical symptoms of heart failure (dyspnea, edema, exertional limitation)
- Obtain natriuretic peptides (BNP or NT-proBNP) to support cardiac etiology
- Perform echocardiography to measure LVEF
- If LVEF ≤40% → Diagnosis of HFrEF confirmed
Critical Pitfalls to Avoid
The single LVEF measurement problem: One measurement may be insufficient, particularly for patients with LVEF in borderline ranges. The trajectory of LVEF over time matters 1. Patients can transition between HF categories, so serial measurements may be needed in unclear cases.
Missing the diagnosis entirely: Real-world data shows that 50% of patients with an ICD-10 code for heart failure lack documented EF data in their medical records 5. This represents a major diagnostic gap—always ensure LVEF is formally assessed and documented.
Overreliance on symptoms alone: Clinical signs and symptoms are frequently nonspecific and overlap with other conditions (obesity, deconditioning, pulmonary disease) 1. The combination of symptoms + reduced LVEF + elevated natriuretic peptides provides diagnostic specificity.